The Wild laboratory is located at the University Hospital of Zurich. The research program is devoted to the identification of clinically significant biomarkers for cancer and their implications for prognosis, therapy response, and classification of the disease and other fields described in Research.


The laboratory is exceptionally well equipped with next-generation sequencing platforms (Ion Torrent Proton, Ion Torrent PGM, Ion Torrent S5, Illumina MiSeq), real-time cell viability assays, a Q Exactive HF MS system (Thermo Fisher Scientific), fluorescence in situ hybridization (FISH) devices, and an Idylla Biocartis system.


Illumina MiSeq

Ion Torrent S5

Ion Torrent PGM

Ion Torrent Proton


Mass Spectrometer